Improvement in Sexual Quality of Life of the Female Partner Following Vardenafil Treatment of Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled Study

Journal of Sexual Medicine

Volumn 8, Issue 10, 2011, Pages 2831-2840

  Martín Morales, Antonio ^a   Graziottin, Alessandra ^b   Jaoudé, Gilbert Bou ^c   Debruyne, Frans ^d   Buvat, Jacques ^c   Beneke, Manfred ^e   Neuser, Dieter ^e  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Centre d'Etude et de Traitement de la Pathologie de l'Appareil Reproducteur et de la Psychosomatique   (France)

^d ANDROS Mannenkliniek   (Netherlands)

^e BAYER PHARMA AG   (Germany)

Author keywords

Couple Sexual Function; Erectile Dysfunction; Female Sexual Dysfunction; Female Sexual Function; Phosphodiesterase Type 5 Inhibitor; Sexual Quality of Life of Female Partner; Vardenafil

Indexed keywords

PLACEBO; VARDENAFIL;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ERECTILE DYSFUNCTION; FEMALE; FLUSHING; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; PENIS ERECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SEXUALITY; SIDE EFFECT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 80053561884     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02352.x     Document Type: Article

References (22)

1. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts male aging study. Prev Med 2000;30:328-38.
2. Kubin M, Wagner G, Fugl-Meyer AR. Epidemiology of erectile dysfunction. Int J Impot Res 2003;15:63-71.
3. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004;20:607-17.
4. Paige NM, Hays RD, Litwin MS, Rajfer J, Shapiro MF. Improvement in emotional well-being and relationships of users of sildenafil. J Urol 2001;166:1774-8.
5. Fisher WA, Rosen RC, Eardley I, Niederberger C, Nadel A, Kaufman J, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: Understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. J Sex Med 2004;1:150-60.
6. Sanchez-Cruz JJ, Cabrera-Leon A, Martin-Morales A, Fernandez A, Burgos R, Rejas J. Male erectile dysfunction and health-related quality of life. Eur Urol 2003;44:245-53.
7. Tomlinson J, Wright D. Impact of erectile dysfunction and its subsequent treatment with sildenafil: Qualitative study. BMJ 2004;328:1037.
8. Zumbé J, Porst H, Sommer F, Grohmann W, Beneke M, Ulbrich E. Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: Findings of the RESTORE study. Eur Urol 2008;54:204-10.
9. Axilrod AC. Phosphodiesterase type 5 inhibitor therapy: Identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction. Curr Med Res Opin 2007;23:3189-98.
10. Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: The female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005;2:675-84.
11. Cayan S, Bozlu M, Canpolat B, Akbay E. The assessment of sexual functions in women with male partners complaining of erectile dysfunction: Does treatment of male sexual dysfunction improve female partner's sexual functions? J Sex Marital Ther 2004;30:333-41.
12. Greenstein A, Abramov L, Matzkin H, Chen J. Sexual dysfunction in women partners of men with erectile dysfunction. Int J Impot Res 2006;18:44-6.
13. Ichikawa T, Takao A, Manabe D, Saegusa M, Tanimoto R, Aramaki K, Yamamoto M, Okazaki T. The female partner's satisfaction with sildenafil citrate treatment of erectile dysfunction. Int J Urol 2004;11:755-62.
14. Heiman JR, Talley DR, Bailen JL, Oskin TA, Rosenberg SJ, Pace CR, Creanga DL, Bavendam T. Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: A multicentre, randomised, double-blind, placebo-controlled trial. BJOG 2007;114:437-47.
15. Lewis R, Bennett CJ, Borkon WD, Boykin WH, Althof SE, Stecher VJ, Siegel RL. Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire. Urology 2001;57:960-5.
16. Fisher WA, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Goldstein I, Bangerter K, Bandel TJ, Derogatis LR, Sand M. Improving the sexual quality of life of couples affected by erectile dysfunction: A double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2005;2:699-708.
17. Goldstein I, Fisher WA, Sand M, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Bangerter K, Bandel TJ, Derogatis LR. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: A prospective, randomized, double-blind, placebo-controlled trial. J Sex Med 2005;2:819-32.
18. Rosen R, Goldstein I, Huang XY, Bangerter K, Taylor T. The Treatment Satisfaction Scale (TSS) is a sensitive measure of treatment effectiveness for both patients and partners: Results of a randomized controlled trial with vardenafil. J Sex Med 2007;4:1009-21.
19. Woodward JM, Hass SL, Woodward PJ. Reliability and validity of the sexual life quality questionnaire (SLQQ). Qual Life Res 2002;11:365-77.
20. Fisher W, Meryn S, Sand M, Brandenburg U, Buvat J, Mendive J, Scott S, Tailor A, Torres LO. Communication about erectile dysfunction among men with ED, partners of men with ED, and physicians: The Strike Up a Conversation study-Part I. J Men's Health Gend 2005;2:64-78.
21. Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples II: Association of female partner characteristics with male partner ED treatment seeking and phosphodiesterase type 5 inhibitor utilization. J Sex Med 2009;6:3111-24.
22. Jackson SE, Lue TF. Erectile dysfunction: Therapy health outcomes. Urology 1998;51:874-82.